Skip to main content
. 2020 Jul 21;10:1084. doi: 10.3389/fonc.2020.01084

Table 3.

Examples of the mechanisms of miRNA-mediated resistance in ovarian cancer.

References miRNA Expression in resistant cells Target gene Suggested mechanism
Xu et al. (148) miR-497 Down mTOR/P70S6K1 The resultant activation of mTOR/P70S6K1 positively affects several downstream effectors to regulate cell growth, proliferation, and survival (149).
Chen et al. (150) miR-133b Down GST-π GSTs have the ability to detoxify cytostatic drugs (151). Therefore, chemotherapy-resistant ovarian cancer cells might develop resistance by upregulating the miR-133b-target gene GST-π.
van Jaarsveld et al. (152) miR-634 Down CCND1, GRB2, ERK2, and RSK2 Upregulation and activation of these MAPK pathway components produce undesirable effects on several fundamental cellular processes, including cell cycle progression and inhibition of apoptosis (153).
Dwivedi et al. (154) miR-15a miR-16 Down BMI1 Bmi1, a member of the Polycomb Repressor Complex 1, is a crucial regulator of the self-renewal and malignant transformation of many cancers (see Table 2).
Cui et al. (155) miR-146a Down SOD2 Resistant cells have shown higher levels of the antioxidant SOD2, which scavenge any reactive species produced by the chemotherapy and thus resist death (156).
Guo et al. (157) miR-100 Down mTOR and PLK1 Cells are able to develop resistance by enhancing the functions of the mitotic regulator gene Polo-like kinase 1 (Plk1) (158), in addition to the other oncogenic roles of mTOR (see above).
Zhu et al. (159) miR-186 Down Twist1 Twist1 can confer chemoresistance in different cancers by regulating several downstream signaling proteins, including mTOR and Bcl2. In addition, Twist1 binds and activates ABC transporters, mediates EMT-induced resistance, and positively regulates PI3K/AKT pathway (160).
Han et al. (161) miR-30a/c-5p Down Snail DNMT1-mediated silencing of miR-30a/c-5p upregulates E-cadherin-transcriptional repressor Snail, thereby promoting EMT-mediated resistance to cisplatin.
Vera et al. (162) miR-7 Down MAFG Recent evidence suggests that MAFG confers antioxidant activity against free radicals produced as a result of cisplatin treatment, which might be the mechanism behind MAFG-induced cisplatin resistance (163).
Jiang et al. (164) miR-139-5p Down C-Jun The resultant overexpression of the proto-oncogene c-Jun promotes the expression of the anti-apoptotic protein Bcl-XL, thereby suppressing the apoptotic death of these cells.
Kanlikilicer et al. (165) miR-1246 Up Cav1 Upregulated miR-1246 potentiates resistance toward paclitaxel through the downregulation of Cav1, a protein that directly binds and inhibits the kinase activity of the platelet-derived growth factor receptor PDGFRβ, which correlates with induction of the p-glycoprotein (MDR1) levels.
Chen et al. (166) miR-139-5p Down RNF2 Evidence suggests that ovarian cancer cells can develop resistance by upregulating the ring finger protein 2, RNF2, an E3 ligase that targets the tumor suppressor p53 for degradation, thereby inhibiting cellular apoptosis (167).
Zhang et al. (168) miR-1294 Down IGF1R See Table 2
Xu et al. (169) miR-378a-3p Down MAPK1/GRB2 See above
Jiang et al. (170) miR-383-5p Down TRIM27 See above
Sun et al. (171) miR-137 Down EZH2 EZH2 functions as a transcriptional suppressor or a transcriptional co-activator through epigenetic regulation of histone methylation. Evidence has shown that the upregulation of EZH2 strongly correlates with cisplatin resistance (172, 173).
Park and Kim (174) miR-503-5p Down CD97 CD97 is a member of the epidermal growth factor (EGF)-seven transmembrane family that signals through Janus-activated kinase 2(JAK2), a signal transducer and activator of transcription 3 (STAT3), to induce paclitaxel resistance in ovarian carcinoma.
Nakamura et al. (175) miR-194-5p Down MDM2 Upregulation of the E3 ubiquitin ligase, MDM2, blocks the transcriptional activity of several tumor suppressor genes, including p53 and p21.
Li et al. (176) miR-142-5p Down XIAP See Table 2.
Zhang et al. (177) miR-574-3p Down EGFR Cells might confer resistance toward chemotherapies by activating several signaling cascades involved in proliferation and survival that are downstream of the oncogenic EGFR (178).
Dai et al. (179) miR-195-5p Down PSAT1 PSAT1-promotes inactivating phosphorylation of GSK3β, allowing the accumulation and nuclear translocation of β-catenin, which might help in conferring resistance by upregulating the stress-related gene, HIF-1α.